Back to Search
Start Over
High-grade Glioma Market 2032: Epidemiology Trends, Innovative Therapies, Regulatory Approvals by DelveInsight | Everfront Biotech Co., Ltd., BioMimetix JV, LLC, Chimerix, Laminar Pharma
- Source :
- M2 Presswire. May 14, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PRESSWIRE-May 14, 2024-: High-grade Glioma Market 2032: Epidemiology Trends, Innovative Therapies, Regulatory Approvals by DelveInsight | Everfront Biotech Co., Ltd., BioMimetix JV, LLC, Chimerix, Laminar Pharma (C)1994-2024 M2 COMMUNICATIONS [...]
- Subjects :
- Business -- Research
Antineoplastic agents -- Reports -- Forecasts and trends
Biotechnology -- Reports -- Forecasts and trends
Gliomas -- Forecasts and trends -- Reports
Epidemiology -- Forecasts and trends -- Reports
Antimitotic agents -- Reports -- Forecasts and trends
Company joint venture
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.793710530